How many insider trades does FilingIQ track for BIOA?

FilingIQ tracks 123 Form 4 insider transactions for BIOA (BioAge Labs, Inc.), covering filings from May 15, 2015 onwards. 20 of those were filed in the last 90 days.

Are BIOA insiders net buyers or net sellers?

Across the full Form 4 history for BIOA, 43 transactions (35%) were open-market purchases and 11 (9%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does BIOA insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is BIOA in?

BioAge Labs, Inc. (BIOA) is classified in the Healthcare sector, specifically Drug Manufacturers - Specialty & Generic, with a current market capitalisation of $890.58M.

BIOA insider trading

NasdaqGS Healthcare

BioAge Labs, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

123

Last 90 days

Buys / sells

35% / 9%

Market cap

$890.58M

About BioAge Labs, Inc.

BioAge Labs, Inc. is a biopharmaceutical company that develops therapeutic product candidates for metabolic diseases. The company's technology platform and differentiated human datasets that allows users to identify targets based on insights into molecular changes that drive aging. It also provides azelaprag, an orally available small molecule that is in phase 1 clinical trial for the treatment of obesity; and initiated phase 2 clinical trial of azelaprag in combination with tirzepatide for the treatment of obesity in older adults. It develops BGE-102, an orally available small molecule brain-penetrant NLRP3 antagonist for the treatment of diseases driven by neuroinflammation. The company was incorporated in 2015 and is based in Richmond, California.

Company website: bioagelabs.com

BIOA insider activity at a glance

FilingIQ has scored 123 insider transactions for BIOA since May 15, 2015. The most recent filing in our index is dated Apr 23, 2026.

Across the full history, 43 open-market purchases and 11 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on BIOA insider trades is 54.2/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live BIOA trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Frequently asked

How many insider trades does FilingIQ track for BIOA?: FilingIQ tracks 123 Form 4 insider transactions for BIOA (BioAge Labs, Inc.), covering filings from May 15, 2015 onwards. 20 of those were filed in the last 90 days.
Are BIOA insiders net buyers or net sellers?: Across the full Form 4 history for BIOA, 43 transactions (35%) were open-market purchases and 11 (9%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does BIOA insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is BIOA in?: BioAge Labs, Inc. (BIOA) is classified in the Healthcare sector, specifically Drug Manufacturers - Specialty & Generic, with a current market capitalisation of $890.58M.

Methodology & sources

Every BIOA insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.